Recent publications
Article
Kissoonsingh, P, Sutton, B, Iqbal, SU, Pallan, L, Steven, N & Khoja, L 2022, 'Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient', Case reports in oncological medicine, vol. 2022, 2658136. https://doi.org/10.1155/2022/2658136
Pascoe, J, Jackson, A, Gaskell, C, Gaunt, C, Thompson, J, Billingham, L & Steven, N 2021, 'Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)', BMC Cancer, vol. 21, no. 1, 800. https://doi.org/10.1186/s12885-021-08519-8
Chrysostomou, S, Roy, R, Prischi, F, Thamlikitkul, L, Chapman, KL, Mufti, U, Peach, R, Ding, L, Hancock, D, Moore, C, Molina-Arcas, M, Mauri, F, Pinato, DJ, Abrahams, JM, Ottaviani, S, Castellano, L, Giamas, G, Pascoe, J, Moonamale, D, Pirrie, S, Gaunt, C, Billingham, L, Steven, NM, Cullen, M, Hrouda, D, Winkler, M, Post, J, Cohen, P, Salpeter, SJ, Bar, V, Zundelevich, A, Golan, S, Leibovici, D, Lara, R, Klug, DR, Yaliraki, SN, Barahona, M, Wang, Y, Downward, J, Skehel, JM, Ali, MMU, Seckl, MJ & Pardo, OE 2021, 'Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer', Science Translational Medicine, vol. 13, no. 602, eaba4627. https://doi.org/10.1126/SCITRANSLMED.ABA4627
Ford, M, Sahbudin, I, Filer, A, Steven, N & Fisher, B 2018, 'High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis', Rheumatology. https://doi.org/10.1093/rheumatology/key234
Harrison, S, Tew, A, Steven, N & Fisher, B 2018, 'Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy', Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/key080
Marsden, JR, Fox, R, Boota, N, Wheatley, K, Billingham, L, Steven, N, Group, TNCRISCCS & Group, UKDCTNATLIMITC 2017, 'Effect of topical imiquimod as primary treatment for lentigo maligna - the LIMIT-1 study', British Journal of Dermatology, vol. 176, no. 5, pp. 1148-1154. https://doi.org/10.1111/bjd.15112
Kempegowda, P, Quinn, L, Vijayan, MA, Jain, A, Steven, N, Gleeson, H & Toogood, A 2017, 'Ipilimumab induced hypophysitis - an insight from a case series in the United Kingdom', Endocrine Abstracts, vol. 49, EP1052. https://doi.org/10.1530/endoabs.49.EP1052
Billingham, L, Malottki, K & Steven, N 2016, 'Research methodology to influence clinical practice for patients with rare cancers', The Lancet Oncology, vol. 17, no. 2, pp. e70-e80. https://doi.org/10.1016/S1470-2045(15)00396-4, https://doi.org/10.1016/S1470-2045(15)00396-4, https://doi.org/10.1016/S1470-2045(15)00396-4
Johnson, P, Challis, R, Chowdhury, F, Gao, Y, Harvey, M, Geldart, T, Kerr, P, Chan, C, Smith, A, Steven, N, Edwards, C, Ashton-Key, M, Hodges, E, Tutt, A, Ottensmeier, C, Glennie, M & Williams, A 2015, 'Clinical and biological effects of an agonist anti-CD40 antibody: a cancer research UK phase I study', Clinical Cancer Research, vol. 21, no. 6, pp. 1321-1328. https://doi.org/10.1158/1078-0432.CCR-14-2355
Knight, LM, Stakaityte, G, Wood, JJ, Abdul-Sada, H, Griffiths, DA, Howell, GJ, Wheat, R, Blair, GE, Steven, NM, Macdonald, A, Blackbourn, DJ & Whitehouse, A 2015, 'Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration', Journal of virology, vol. 89, no. 1, pp. 35-47. https://doi.org/10.1128/JVI.02317-14
Zhuang, X, Ahmed, F, Zhang, Y, Ferguson, H, Steele, JC, Steven, NM, Nagy, Z, Heath, VL, Toellner, K-M & Bicknell, R 2015, 'Robo4 vaccines induce antibodies that retard tumor growth', Angiogenesis, vol. 18, no. 1, pp. 83-95. https://doi.org/10.1007/s10456-014-9448-z
Angevin, E, Tabernero, J, Elez, E, Cohen, SJ, Bahleda, R, van Laethem, J-L, Ottensmeier, C, Lopez-Martin, JA, Clive, S, Joly, F, Ray-Coquard, I, Dirix, L, Machiels, J-P, Steven, N, Reddy, M, Hall, B, Puchalski, TA, Bandekar, R, van de Velde, H, Tromp, B, Vermeulen, J & Kurzrock, R 2014, 'A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors', Clinical Cancer Research, vol. 20, no. 8, pp. 2192-204. https://doi.org/10.1158/1078-0432.CCR-13-2200
Taylor, GS, Jia, H, Harrington, K, Lee, LW, Turner, JE, Ladell, K, Price, DA, Tanday, M, Matthews, J, Roberts, C, Edwards, C, McGuigan, L, Hartley, A, Wilson, S, Hui, EP, Chan, ATC, Rickinson, AB & Steven, NM 2014, 'A recombinant modified vaccinia Ankara vaccine encoding Epstein-Barr virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer', Clinical Cancer Research, vol. 20, no. 19, pp. 5009-5022. https://doi.org/10.1158/1078-0432.CCR-14-1122-T
Taylor, GS, Jia, H, Harrington, K, Lee, LW, Turner, J, Ladell, K, Price, DA, Tanday, M, Matthews, J, Roberts, C, Edwards, C, McGuigan, L, Hartley, A, Wilson, S, Hui, EP, Chan, ATC, Rickinson, AB & Steven, NM 2014, 'A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer', Clinical Cancer Research, vol. 20, no. 19, pp. 5009-5022. https://doi.org/10.1158/1078-0432.CCR-14-1122-T
Khan, MWA, Curbishley, SM, Chen, H-C, Thomas, AD, Pircher, H, Mavilio, D, Steven, NM, Eberl, M & Moser, B 2014, 'Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions', Frontiers in immunology, vol. 5, 344. https://doi.org/10.3389/fimmu.2014.00344
View all publications in research portal